Editorial tion, the elongating strand in AAV DNA synthesis has a Site-specific integration by adenopropensity to switch template strands.
associated virus: a basis for a potential have gained a detailed knowledge of some of the molecugene therapy vector lar mechanisms underlying AAV site-specific integration, it is important to note that all of the information to date Recently there has been considerable interest in the possible use of adeno-associated virus (AAV) as a vector for has been gained through studies in cell culture. Studies have been started in animal models with both wild-type human gene therapy.
1 AAV has not been implicated as the cause of any disease; indeed, in cell cultures and anivirus and vectors, but detailed knowledge on tissue distribution and integration is not yet at hand. However, in mal model systems it is anti-oncogenic. Possibly the most striking property of the virus is its inability to proseveral instances the vector DNA has persisted for many months and there has been evidence for continued ductively infect healthy cells in culture in the absence of a co-infection by a helper virus (either adenovirus or expression of the transduced gene.
10
All of the vectors which have been developed to date herpesvirus).
2 Thus, AAV vectors are inherently replication defective. Additional features of the virus which have foreign sequences inserted between the inverted terminal repeats (ITR) of the AAV genome. The ITR is enhance its desirability as a vector include its wide host range and the stability of the virion. Genetic analysis has required for both packaging of the genome and site-specific integration. However, as noted above, the AAV Rep been aided by the fact that the cloned viral DNA is infectious in the presence of helper virus, a feature that greatly protein is required to mediate site-specific integration. Vectors which lack the rep gene can integrate into the simplifies production of recombinant virus particles. Infection in the absence of helper virus leads to integenome, but the frequency of such nonspecific integration is unknown. The rep gene has been deleted from gration of the AAV genome at a specific site on the q arm of chromosome 19 to establish a latent infection. [3] [4] [5] This the vectors for two reasons. The first is that the small size of the genome frequently precludes the inclusion of any is the only known example of site-specific integration by a mammalian virus and suggests the possibility of a vec-AAV sequences beyond the ITR. The second is that detectable levels of rep expression are cytotoxic to many tor which can be inserted at a known site in the human genome. In human cell culture there is little evidence of cells. Therefore, there is concern that a vector containing a rep gene might be toxic and thus unacceptable. significant effect on the phenotype caused by latency. However, it should be noted that no cases have been Although this has not been observed with wild-type AAV, it is not certain that this would also be the case for detected in which both copies of an unoccupied preintegration site are disrupted by AAV integration. Thus, it is a vector. This is particularly the case after integration of the vector. Will the rep gene in an integrated vector possible that integration at more than one preintegration site is lethal, albeit the likelihood of this happening in a remain repressed? Of additional concern is that the presence of a rep gene in the integrated genome renders it significant number of cells in an intact host seems unlikely. An additional advantage of AAV as a vector is potentially susceptible to rescue after superinfection by a helper or exposure of the cell to conditions which would that a latent infection can be established in nondividing cells, although only at several per cent of the frequency render it permissive for AAV replication. In spite of these concerns, development of vectors which involve the presseen in dividing cells. The target sequence for integration has been cloned and sequenced and is upstream from an ence of Rep would allow the vector to be preferentially inserted at a specific site in the cellular genome and thus, open reading frame which is transcribed at a low level in several tissues. The critical sequences for site-specific there would be a more controlled administration of the gene to be transduced. There are two approaches to resolintegration have been determined to reside in a 33 nucleotide sequence which contains two signal sequences that ution of the conundrum posed by the potential advantages of the presence of Rep and the possibly toxic conseplay essential roles in AAV DNA replication. 6 These are a binding site for the AAV Rep protein and an appropriquences of its presence which have been considered. The first of these is to develop a hybrid vector which would ately positioned site which is specifically nicked by the Rep protein. 7 The genetic data are complementary to biocontain both a vector composed of the foreign sequences between two copies of the ITR and a rep gene which chemical data showing Rep interaction with this sequence. A copy choice model involving limited Repwould be sited outside the ITRs. Such a vector might either be a hybrid adenovirus vector or a plasmid. In dependent DNA synthesis has been developed to account for the data. 8, 9 The model takes into account the recent either case the rep gene would be appropriately activated in the recipient cell, not enough to allow productive DNA observation that, in the absence of helper virus co-infec-
